Rabbit Recombinant Monoclonal Aldehyde dehydrogenase 10 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples.
pH: 7.2
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
WB | ICC/IF | Flow Cyt (Intra) | |
---|---|---|---|
Human | Tested | Tested | Tested |
Mouse | Predicted | Predicted | Predicted |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/1000 - 1/10000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/250 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/170 | Notes ab172730 - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody. |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info - | Notes - |
Catalyzes the oxidation of medium and long chain aliphatic aldehydes to fatty acids. Active on a variety of saturated and unsaturated aliphatic aldehydes between 6 and 24 carbons in length (PubMed:18035827, PubMed:18182499, PubMed:22633490, PubMed:25047030, PubMed:9133646, PubMed:9662422). Responsible for conversion of the sphingosine 1-phosphate (S1P) degradation product hexadecenal to hexadecenoic acid (PubMed:22633490).
ALDH10, FALDH, ALDH3A2, Aldehyde dehydrogenase family 3 member A2, Aldehyde dehydrogenase 10, Fatty aldehyde dehydrogenase, Microsomal aldehyde dehydrogenase
Rabbit Recombinant Monoclonal Aldehyde dehydrogenase 10 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples.
pH: 7.2
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Aldehyde dehydrogenase 10 (ALDH10) functions mechanically as an enzyme that catalyzes the NAD(P)+-dependent oxidation of aldehydes to carboxylic acids. It belongs to a larger family of aldehyde dehydrogenases. Frequently used alternate names include ALDH3A2 ensuring clarification across research contexts. The mass of ALDH10 can vary slightly depending on specific isoforms and protein modifications but typically his family is around 50-55 kDa. Expression of ALDH10 mainly occurs in the liver and also in tissues including kidney and lung reflecting its roles in aldehyde metabolism across different tissues.
Aldehyde dehydrogenase 10 participates in the detoxification of aldehydes which are generated during metabolic processes. It plays an important role in protecting cells from oxidative stress by converting reactive aldehydes to less toxic carboxylic acids. ALDH10 does not seem to form part of a larger complex but acts independently to perform its function. Its enzymatic activity impacts cellular redox balance important for maintaining cellular health and function.
Aldehyde dehydrogenase 10 plays a significant role in the metabolic pathway processes involving amino acid and fatty acid metabolism. It is important in metabolizing aldehydes generated through lipid peroxidation and amino acid degradation pathways contributing to maintaining metabolic homeostasis. ALDH10 connects functionally with other aldehyde dehydrogenase family members like ALDH2 and ALDH3A2 which collaborate in handling various aldehyde substrates critical to these pathways.
Aldehyde dehydrogenase 10 holds relevance to conditions like Sjögren-Larsson syndrome and non-alcoholic fatty liver disease. ALDH3A2 a closely related protein links directly with Sjögren-Larsson syndrome due to its known genetic mutations causing reduced enzymatic function. The role of ALDH10 in modulating liver metabolism links it to non-alcoholic fatty liver disease as altered detoxification capability can lead to disease progression. Understanding these relationships helps in targeting therapies that might mitigate disease impacts by enhancing detoxification pathways.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
All lanes: Western blot - Anti-Aldehyde dehydrogenase 10 antibody [EPR15425(B)] (ab184171) at 1/1000 dilution
Lane 1: Wild-type HeLa cell lysate at 20 µg
Lane 2: ALDH3A2 knockout HeLa cell lysate at 20 µg
Lane 2: Western blot - Human ALDH3A2 (Aldehyde dehydrogenase 10) knockout HeLa cell line (Human ALDH3A2 (Aldehyde dehydrogenase 10) knockout HeLa cell line ab265427)
Performed under reducing conditions.
Predicted band size: 55 kDa
Observed band size: 50 kDa
Immunofluorescence analysis of 4% paraformaldehyde fixed A549 cells labeling Aldehyde dehydrogenase 10 using ab184171 at 1/250 dilution (red). A Goat anti rabbit IgG (Alexa Fluor555) at 1/200 dilution was used as secondary antibody. Counterstain: DAPI (blue).
Intracellular flow cytometric analysis of 2% paraformaldehyde fixedHepG2 cells labeling Aldehyde dehydrogenase 10 using ab184171 at 1/170 dilution (red). A Goat anti rabbit IgG (FITC) at 1/150 dilution was used as secondary antibody. Isotype control: Rabbit monoclonal IgG (green).
All lanes: Western blot - Anti-Aldehyde dehydrogenase 10 antibody [EPR15425(B)] (ab184171) at 1/10000 dilution
All lanes: U87-MG cell lysate at 20 µg
All lanes: Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 55 kDa
All lanes: Western blot - Anti-Aldehyde dehydrogenase 10 antibody [EPR15425(B)] (ab184171) at 1/2000 dilution
Lane 1: A549 cell lysate at 20 µg
Lane 2: 293T cell lysate at 20 µg
All lanes: Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 55 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com